Related Experiment Video
Updated: Apr 19, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
How I treat bladder cancer in elderly patients
1Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract:
Bladder cancer is a disease of the elderly. There is a disconnect between the efficacy of treatments for patients with advanced disease, and their effectiveness, at least in part related to the advanced age at diagnosis. Standard treatments for patients with locally advanced or metastatic bladder cancer include radical cystectomy and/or cisplatin-based combination chemotherapy. However, there is significant potential for morbidity, and even mortality, with these treatments necessitating tools to risk stratify elderly patients to optimize the safety and benefit of treatments and alternative strategies in situations where the potential risks are likely to outweigh the potential benefits. This review considers the current standard treatments for advanced bladder cancer, approaches to risk stratify elderly patients, and highlights our relatively poor knowledge base regarding the optimal care of elderly patients with this disease.
Related Concept Videos
Urinary Tract Calculi V: Nursing Management
Urinary Tract Calculi III: Medical Management
Drug Dosing: Geriatric Patients
Urinary Tract Infection IV: Nursing Management
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Urinary Tract Calculi VI: Surgical Management

